10+ can't-miss Houston business and innovation events for August

WHERE TO BE

Houston innovators — put these August events on your radar. Photo via Getty Images

From networking meet-ups to expert startup showcases, August is filled with opportunities for Houston innovators.
Here's a roundup of events you won't want to miss out on so mark your calendars and register accordingly.

Note: This post may be updated to add more events.

August 1 — 7th Annual Summer Science Symposium

The 7th Annual MAPTA Summer Science Symposium will showcase work from research trainees, postdoctoral fellows, and medical residents. The symposium will feature all fields of translational, basic science and clinical research. This two-day in-person event will include both poster and oral presentations.

Keynote Speakers:

Brijesh S. “Billy” Gill, MD, FACS
Corina Rosales, PhD

This event is Thursday, August 1, from 9 am to 4 pm at Houston Methodist Research Institute. Click here to register.

August 1 — Bayou Startup Showcase

The Bayou Startup Showcase is a dynamic celebration of entrepreneurship, spotlighting the newest startups and small businesses from Rice University’s OwlSpark and the University of Houston’s RED Labs accelerators. Attendees can listen to pitches, discover ways to support and grow these businesses, and engage with founders during the showcase.

This event is Thursday, August 1, from 4 to 8 pm at The Ion. Click here to register.

August 8 — Out In Tech Mixer

Out in Tech Houston provides an inclusive networking space for LGBTQ+ people and allies working in tech. Check out this relaxed, social-mixer event, hosted on the second Thursday of every month.

This event is Thursday, August 8, from 7 to 8:30 pm at Second Draught. Click here to register.

August 13 — Software Day at The Ion: An Intro to Central Texas Seed Stage VCs

Software Day is a monthly series driving the support, inspiration, and connections needed to help startups on their path to rapid, sustainable growth. Each month, Software Day will include office hours (by application), a keynote session, and networking.

Speakers include:

  • Eric Engineer, S3 Ventures
  • Rajiv Bala, Clutch Ventures
  • Cat Dizon, Active Capital
  • Mike Marcantonio, LiveOak
  • Moderator: Aziz Gilani, Mercury
This event is Tuesday, August 13, from 3:30 to 7 pm at The Ion. Click here to register.

August 15 — TMC Lunch ‘n’ Launch: Phiogen

This monthly event series hosted by TMC Innovation highlights TMC community companies and provides them with a platform to share their journey, current progress, and future goals. This month the lunch features Phiogen, a specialized phage therapy corporation founded by by Baylor College of Medicine.

This event is Thursday, August 15, from 12 to 1 pm at at TMC Innovation Factory. Click here to register.

August 15 — SPRINT Workforce Forum

This two-day event brings together industry, universities, and government entities to discuss the workforce challenges that arise from the rapidly advancing AI and robotics technologies in the energy sector. It has a special emphasis on inspiring students to become advocates of AI and robotics, enabling them to help the energy industry’s digital transformation.

This event is Thursday, August 15, starting at 12 am at Student Center South and UH Hilton. Click here to register.

August 22 — Transition On Tap

Transition On Tap is Greentown Labs’ monthly networking event devoted to fostering conversations and connections among the climate and energy transition ecosystem in Houston and beyond. Entrepreneurs, investors, students, and friends of climatetech are invited to attend, meet colleagues, and discuss solutions.

This event is Thursday, August 22 from 5:30 to 7:30 pm at Greentown Houston. Click here to register.

August 23 — 2024 Cardiometabolic Syndrome Conference: A Population Health Crisis

The Cardiometabolic Syndrome Conference is designed to provide attendees with the most contemporary knowledge about the syndrome, including the epidemiology, treatment strategies, and knowledge gaps. There will be a specific focus on high-level discussions that dissect the current shortcomings in the overall management of CMS at the individual and community level and begin to consider new and innovative treatment strategies.

This event is Friday, August 23 from 7 am to 5 pm at The Texas Heart Institute. Click here to register.

August 28 — TMCi Cappuccino Connections

Network with the diverse TMC Innovation Community while enjoying a cup of joe.

This event is Wednesday, August 28, from 8:30 am to 10:30 am at TMC Innovation Factory Lobby. Click here to register.

August 28 — Bayou City Bio Pulse: Pearland

Hear from some of the region’s largest commercial life science manufacturers. This panel discussion will examine the obstacles and potential avenues for the growth of commercial life science firms. Tours of Lonza’s and Millar’s manufacturing facilities will follow the program.

This event is Wednesday, August 28, from 11 am to 2 pm at West Pearland Library. Click here to register.

August 29 — SaaStock Local: Scalability in the Age of AI, Building for Growth in SaaS

Attendees will explore innovative strategies and cutting-edge technologies designed to enhance scalability, ensuring that cloud computing environments remain robust, flexible, and capable of supporting dynamic and complex AI workloads. The session will cover best practices for optimizing resource allocation, managing data efficiently, and maintaining high performance as demand increases.

This event is Thursday, August 29, from 5:30 to 8 pm at The Ion. Click here to register.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

New UH survey reveals concerns over AI data center growth in Houston

data findings

A new report out of the University of Houston shows that area residents remain wary of the long-term effects of operating data centers.

The recent survey from the University of Houston’s latest SPACE City Panel, conducted by the Center for Public Policy at the Hobby School of Public Affairs, shows that while 85 percent of Houston-area residents use AI, nearly 63 percent oppose the construction of AI data centers within 1 mile of their homes.

Respondents’ concerns centered around data centers’ high energy demand and the area’s power grid reliability. According to the survey, 32 percent of residents who oppose local data center projects would be more likely to support the centers if they relied on renewable energy over fossil fuels.

“Respondents understand that AI can bring economic and educational benefits, but they are also concerned about the physical infrastructure needed to fuel AI, especially data centers,” Soran Mohtadi, post-doctoral fellow at the Hobby School and a researcher on the report, said in a news release. “This physical infrastructure demands more electricity and water, leading to environmental impacts.”

Experts estimate that 6.5 gigawatts of data center capacity will be added to the Texas grid by 2030. And Houston’s data center capacity is predicted to more than double by 2028.

The Electric Reliability Council of Texas also projects electricity demand could reach 218 gigawatts by 2031, which would be more than double the record peak set in August 2023. Data centers are expected to account for 86 gigawatts of that new demand.

Survey respondents also said they are concerned about the state's future water supply, given the large amounts of water that data centers need to stay cool.

In terms of who’s responsible for that issue, 57.6 percent of respondents said they put the onus on Texas lawmakers, while 31.5 percent say tech companies should be responsible.

Additionally, more than 75 percent of respondents believed that data center developers and technology companies—not residents—should bear the cost of infrastructure upgrades to support data centers.

“Every decision legislators make has implications on residents’ everyday lives and local infrastructure now and in the future,” Maria P. Perez Arguelles, lead researcher on the report and research assistant professor at the Hobby School, added in the news release. “This issue is going to become more important in years to come, so this is just the beginning.”

Read the full report here.

Houston-born Cemvita makes breakthrough in sustainable fuel production

clean fuels

Houston-based biotech company Cemvita announced that it recently reached a critical milestone in the development of its FermOil product, which can be used to create Sustainable Aviation Fuel (SAF) and other renewable fuels at industrial scale.

The company shared in a news release that it completed a 75,000-liter industrial fermentation run at Belgium's Bio Base Europe Pilot Plant.

The campaign achieved target technical metrics for the production of FermOil, Cemvita’s renewable natural oil (RNO). FermOil is produced from industrial crude glycerin, an industrial byproduct, as opposed to traditional sugar-based feedstocks used in many bio-oil fermentation processes. It's designed to be a drop-in feedstock for creating SAFs.

Cemvita had previously advanced its FermOil production process through multiple scale-up stages before successfully reaching the 75,000-liter demonstration campaign, according to the company.

“This is not just a fermentation milestone,” Moji Karimi, CEO at Cemvita, said in the release. “It is a blueprint for how existing industrial infrastructure can evolve into circular bioeconomy infrastructure. Every biodiesel plant generating crude glycerin is a potential platform for renewable natural oil production.”

The milestone also supports the deployment of Cemvita’s industrial biomanufacturing platform, FermWorks, which integrates with existing energy and industrial infrastructure to turn waste carbon streams into SAFs and other materials. According to the release, Cemvita plans to move forward with commercial deployment discussions with partners in Brazil, Europe and in the UK. Cemvita already has a partnership with the Brazilian sustainable research institution REMA.

“We are proud to support innovative companies like Cemvita in scaling breakthrough industrial biotechnology solutions,” Hendrik Waegeman, head of business operations at Bio Base Europe Pilot Plant, added in the release. “Successfully operating at the 75,000-liter scale using a feedstock such as crude glycerin highlights both the maturity of the technology and the quality of the scale-up execution achieved by the Cemvita team.”

---

This article originally appeared on our sister site, EnergyCapitalHTX.com.

Eli Lilly scoops up Houston biotech startup in $300 million deal

big pharma deal

Pharmaceutical giant Eli Lilly has acquired Houston biotech startup CrossBridge Bio, which develops antibody-drug conjugates for cancer, in a deal worth up to $300 million. The deal was celebrated by TMC Venture Fund and the University of Texas Health Science Center at Houston last week.

CrossBridge, founded in 2023, is developing ADCs based on research by Kyoji Tsuchikama and Zhiqiang An, both of UT Health Houston. Tsuchikama is an associate professor of medicinal chemistry and a globally recognized ADC pioneer, and An is a professor of molecular science and vice president of drug discovery.

Antibody-drug conjugates (ADCs) are a potent combination of targeted therapy and chemotherapy that kills cancer cells while saving healthy tissue.

Clinical trials for CrossBridge’s primary ADC candidate, CBB-120, are expected to start this year, pending approval from the U.S. Food and Drug Administration (FDA).

“I’m proud of how well our team has executed and advanced our platform in such a short time since the company’s founding,” Michael Torres, co-founder and CEO of CrossBridge, said in a news release. “By becoming a part of Lilly, a leader in patient-focused therapeutic development, we are well-positioned to further accelerate the clinical potential of this approach.”

Under the Lilly deal, CrossBridge shareholders were expected to receive an upfront payment along with a follow-up payment based on the achievement of certain milestones.

In 2024, CrossBridge closed a $10 million seed round. Among the investors in CrossBridge are the Texas Medical Center Venture Fund, CE-Ventures, Alexandria Venture Investments, Portal Innovations, Linden Lake Labs, and the Cancer Prevention and Research Institute of Texas (CPRIT). It was formed in TMC Innovation’s Accelerator for Cancer Therapeutics program."Built within the TMC ecosystem, CrossBridge Bio grew with the support, funding, and resources that helped shape its trajectory. TMC led the company's early financing and watched it evolve from its earliest days to its acquisition by Eli Lilly," William McKeon, president and CEO of the Texas Medical Center, shared in a LinkedIn post. "[This is a] strong reminder that breakthrough science and the right early backing can change what’s possible."
View All Listings